Artificial Intelligence at Lilly | Emerj Artificial Intelligence Research [Video]

Lilly and Company is a global pharmaceutical corporation founded in 1876 and headquartered in Indianapolis, Indiana. The company has offices in 18 countries and sells its products in approximately 125 countries worldwide. As of 2024, Lilly employs over 38,000 people globally and has an annual revenue of $34.12 billion. 

The company’s research and development efforts focus primarily on diabetes, cancer, immunology, pain management, and neurodegeneration. Lilly is renowned for developing breakthrough medications such as Prozac (fluoxetine) for clinical depression, Cymbalta (duloxetine), and the antipsychotic Zyprexa (olanzapine).

Lilly’s AI initiatives have already saved approximately 1.4 million hours of human work, equivalent to about 160 years of 24/7 human work, and they aim to double this to 2.4 million hours by the end of the year. 

This article explores two compelling use cases that illustrate how Eli Lily AI initiatives are actively supporting its strategic business objectives:

• Leveraging generative AI (GenAI) for content automation:Utilizing GenAI to automate …